|
1
|
Agic A, Djalali S, Diedrich K and Hornung
D: Apoptosis in endometriosis. Gynecol Obstet Invest. 68:217–223.
2009. View Article : Google Scholar
|
|
2
|
Kajihara H, Yamada Y, Kanayama S, Furukawa
N, Noguchi T, Haruta S, Yoshida S, Sado T, Oi H and Kobayashi H:
New insights into the pathophysiology of endometriosis: from
chronic inflammation to danger signal. Gynecol Endocrinol.
27:73–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Malhotra N, Karmakar D, Tripathi V, Luthra
K and Kumar S: Correlation of angiogenic cytokines-leptin and IL-8
in stage, type and presentation of endometriosis. Gynecol
Endocrinol. 28:224–227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khoufache K, Michaud N, Harir N, Kibangou
Bondza P and Akoum A: Anomalies in the inflammatory response in
endometriosis and possible consequences: a review. Minerva
Endocrinol. 37:75–92. 2012.PubMed/NCBI
|
|
5
|
Kirchhoff D, Kaulfuss S, Fuhrmann U,
Maurer M and Zollner TM: Mast cells in endometriosis: guilty or
innocent bystanders? Expert Opin Ther Targets. 16:237–241. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Menzies FM, Shepherd MC, Nibbs RJ and
Nelson SM: The role of mast cells and their mediators in
reproduction, pregnancy and labour. Hum Reprod Update. 17:383–396.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Asante A and Taylor RN: Endometriosis: the
role of neuroangiogenesis. Annu Rev Physiol. 73:163–182. 2011.
View Article : Google Scholar
|
|
8
|
D’Cruz OJ and Uckun FM: Targeting mast
cells in endometriosis with janus kinase 3 inhibitor, JANEX-1. Am J
Reprod Immunol. 58:75–97. 2007.PubMed/NCBI
|
|
9
|
Capobianco A, Monno A, Cottone L, Venneri
MA, Biziato D, Di Puppo F, Ferrari S, De Palma M, Manfredi AA and
Rovere-Querini P: Proangiogenic Tie2(+) macrophages infiltrate
human and murine endometriotic lesions and dictate their growth in
a mouse model of the disease. Am J Pathol. 179:2651–2659. 2011.
|
|
10
|
Uz YH, Murk W, Bozkurt I, Kizilay G, Arici
A and Kayisli UA: Increased c-Jun N-terminal kinase activation in
human endometriotic endothelial cells. Histochem Cell Biol.
135:83–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Milewski Ł, Dziunycz P, Barcz E, Radomski
D, Roszkowski PI, Korczak-Kowalska G, Kamiński P and Malejczyk J:
Increased levels of human neutrophil peptides 1, 2, and 3 in
peritoneal fluid of patients with endometriosis: association with
neutrophils, T cells and IL-8. J Reprod Immunol. 91:64–70.
2011.PubMed/NCBI
|
|
12
|
Carli C, Metz CN, Al-Abed Y, Naccache PH
and Akoum A: Up-regulation of cyclooxygenase-2 expression and
prostaglandin E2 production in human endometriotic cells by
macrophage migration inhibitory factor: involvement of novel kinase
signaling pathways. Endocrinology. 150:3128–3137. 2009. View Article : Google Scholar
|
|
13
|
Agic A, Xu H, Finas D, Banz C, Diedrich K
and Hornung D: Is endometriosis associated with systemic
subclinical inflammation? Gynecol Obstet Invest. 62:139–147. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lebovic DI, Chao VA and Taylor RN:
Peritoneal macrophages induce RANTES (regulated on activation,
normal T cell expressed and secreted) chemokine gene transcription
in endometrial stromal cells. J Clin Endocrinol Metab.
89:1397–1401. 2004. View Article : Google Scholar
|
|
15
|
Michaud N, Al-Akoum M, Gagnon G, Girard K,
Blanchet P, Rousseau JA and Akoum A: Decreased concentrations of
soluble interleukin-1 receptor accessory protein levels in the
peritoneal fluid of women with endometriosis. J Reprod Immunol.
92:68–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Franchi L, Warner N, Viani K and Nuñez G:
Function of Nod-like receptors in microbial recognition and host
defense. Immunol Rev. 227:106–128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Khan KN, Kitajima M, Hiraki K, Yamaguchi
N, Katamine S, Matsuyama T, Nakashima M, Fujishita A, Ishimaru T
and Masuzaki H: Escherichia coli contamination of menstrual
blood and effect of bacterial endotoxin on endometriosis. Fertil
Steril. 94:2860–2863. 2010. View Article : Google Scholar
|
|
18
|
Latha M, Vaidya S, Movva S, Chava S,
Govindan S, Govatati S, Banoori M, Hasan Q and Kodati VL: Molecular
pathogenesis of endometriosis; Toll-like receptor-4 A896G (D299G)
polymorphism: a novel explanation. Genet Test Mol Biomarkers.
15:181–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brown J, Wang H, Hajishengallis GN and
Martin M: TLR-signaling networks: an integration of adaptor
molecules, kinases, and cross-talk. J Dent Res. 90:417–427. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tong Y, Cui J, Li Q, Zou J, Wang HY and
Wang RF: Enhanced TLR-induced NF-κB signaling and type I interferon
responses in NLRC5 deficient mice. Cell Res. 22:822–835. 2012.
|
|
21
|
Kobayashi H, Yamada Y, Kanayama S,
Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T and Oi
H: The role of iron in the pathogenesis of endometriosis. Gynecol
Endocrinol. 25:39–52. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lousse JC, Van Langendonckt A, Defrere S,
Ramos RG, Colette S and Donnez J: Peritoneal endometriosis is an
inflammatory disease. Front Biosci (Elite Ed). 4:23–40. 2012.
View Article : Google Scholar
|
|
23
|
Defrère S, González-Ramos R, Lousse JC,
Colette S, Donnez O, Donnez J and Van Langendonckt A: Insights into
iron and nuclear factor-kappa B (NF-kappaB) involvement in chronic
inflammatory processes in peritoneal endometriosis. Histol
Histopathol. 26:1083–1092. 2011.PubMed/NCBI
|
|
24
|
Lu Y, Sun Q, Zheng Y, Liu X, Geng JG and
Guo SW: The role of nuclear factor-kappa-B p50 subunit in the
development of endometriosis. Front Biosci (Elite Ed). 591–603.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mollen KP, Anand RJ, Tsung A, Prince JM,
Levy RM and Billiar TR: Emerging paradigm: toll-like receptor
4-sentinel for the detection of tissue damage. Shock. 26:430–437.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoque R, Malik AF, Gorelick F and Mehal
WZ: Sterile inflammatory response in acute pancreatitis. Pancreas.
41:353–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zeiser R, Penack O, Holler E and Idzko M:
Danger signals activating innate immunity in graft-versus-host
disease. J Mol Med (Berl). 89:833–845. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Demir AY, Demol H, Puype M, de Goeij AF,
Dunselman GA, Herrler A, Evers JL, Vandekerckhove J and Groothuis
PG: Proteome analysis of human mesothelial cells during epithelial
to mesenchymal transitions induced by shed menstrual effluent.
Proteomics. 4:2608–2623. 2004. View Article : Google Scholar
|
|
29
|
Schaefer L: Extracellular matrix
molecules: endogenous danger signals as new drug targets in kidney
diseases. Curr Opin Pharmacol. 10:185–190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang H, Evankovich J, Yan W, Nace G,
Zhang L, Ross M, Liao X, Billiar T, Xu J, Esmon CT and Tsung A:
Endogenous histones function as alarmins in sterile inflammatory
liver injury through Toll-like receptor 9 in mice. Hepatology.
54:999–1008. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Watanabe A, Taniguchi F, Izawa M, Suou K,
Uegaki T, Takai E, Terakawa N and Harada T: The role of survivin in
the resistance of endometriotic stromal cells to drug-induced
apoptosis. Hum Reprod. 24:3172–3179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Izawa M, Harada T, Deura I, Taniguchi F,
Iwabe T and Terakawa N: Drug-induced apoptosis was markedly
attenuated in endometriotic stromal cells. Hum Reprod. 21:600–604.
2006. View Article : Google Scholar
|
|
33
|
Banu SK, Lee J, Speights VO Jr,
Starzinski-Powitz A and Arosh JA: Selective inhibition of
prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human
endometriotic cells through suppression of ERK1/2, AKT, NFkappaB,
and beta-catenin pathways and activation of intrinsic apoptotic
mechanisms. Mol Endocrinol. 23:1291–1305. 2009. View Article : Google Scholar
|
|
34
|
Braun DP, Ding J, Shaheen F, Willey JC,
Rana N and Dmowski WP: Quantitative expression of
apoptosis-regulating genes in endometrium from women with and
without endometriosis. Fertil Steril. 87:263–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nasu K, Nishida M, Ueda T, Takai N, Bing
S, Narahara H and Miyakawa I: Bufalin induces apoptosis and the
G0/G1 cell cycle arrest of endometriotic stromal cells: a promising
agent for the treatment of endometriosis. Mol Hum Reprod.
11:817–823. 2005. View Article : Google Scholar
|
|
36
|
Laschke MW, Elitzsch A, Scheuer C, Vollmar
B and Menger MD: Selective cyclo-oxygenase-2 inhibition induces
regression of autologous endometrial grafts by down-regulation of
vascular endothelial growth factor-mediated angiogenesis and
stimulation of caspase-3-dependent apoptosis. Fertil Steril.
87:163–171. 2007. View Article : Google Scholar
|
|
37
|
Penna I, Du H, Ferriani R and Taylor HS:
Calpain5 expression is decreased in endometriosis and regulated by
HOXA10 in human endometrial cells. Mol Hum Reprod. 14:613–618.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oku H, Tsuji Y, Kashiwamura SI, Adachi S,
Kubota A, Okamura H and Koyama K: Role of IL-18 in pathogenesis of
endometriosis. Hum Reprod. 19:709–714. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Podgaec S, Dias JA Junior, Chapron C,
Oliveira RM, Baracat EC and Abrão MS: Th1 and Th2 immune responses
related to pelvic endometriosis. Rev Assoc Med Bras. 56:92–98.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hull ML, Johan MZ, Hodge WL, Robertson SA
and Ingman WV: Host-derived TGFB1 deficiency suppresses lesion
development in a mouse model of endometriosis. Am J Pathol.
180:880–887. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Saito A, Osuga Y, Yoshino O, Takamura M,
Hirata T, Hirota Y, Koga K, Harada M, Takemura Y, Yano T and
Taketani Y: TGF-β1 induces proteinase-activated receptor 2 (PAR2)
expression in endometriotic stromal cells and stimulates PAR2
activation-induced secretion of IL-6. Hum Reprod. 26:1892–1898.
2011.
|
|
42
|
González-Ramos R, Van Langendonckt A,
Defrère S, Lousse JC, Mettlen M, Guillet A and Donnez J: Agents
blocking the nuclear factor-kappaB pathway are effective inhibitors
of endometriosis in an in vivo experimental model. Gynecol Obstet
Invest. 65:174–186. 2008.PubMed/NCBI
|
|
43
|
Nasu K, Nishida M, Ueda T, Yuge A, Takai N
and Narahara H: Application of the nuclear factor-kappaB inhibitor
BAY 11–7085 for the treatment of endometriosis: an in vitro study.
Am J Physiol Endocrinol Metab. 293:E16–E23. 2007.
|
|
44
|
Nishida M, Nasu K, Ueda T, Yuge A, Takai N
and Narahara H: Beta-hydroxyisovalerylshikonin induces apoptosis
and G0/G1 cell-cycle arrest of endometriotic stromal cells: a
preliminary in vitro study. Hum Reprod. 21:2850–2856. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Laschke MW, Elitzsch A, Scheuer C,
Holstein JH, Vollmar B and Menger MD: Rapamycin induces regression
of endometriotic lesions by inhibiting neovascularization and cell
proliferation. Br J Pharmacol. 149:137–144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Khan KN, Kitajima M, Imamura T, Hiraki K,
Fujishita A, Sekine I, Ishimaru T and Masuzaki H: Toll-like
receptor 4-mediated growth of endometriosis by human heat-shock
protein 70. Hum Reprod. 23:2210–2219. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Defrère S, Van Langendonckt A, Vaesen S,
Jouret M, González Ramos R, Gonzalez D and Donnez J: Iron overload
enhances epithelial cell proliferation in endometriotic lesions
induced in a murine model. Hum Reprod. 21:2810–2816.
2006.PubMed/NCBI
|
